Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Iliskovic

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|September 24, 1998
Doxorubicin-induced cardiomyopathyP K Singal, N Iliskovic
The American Journal of Pathology|February 1, 1997
Lipid lowering: an important factor in preventing adriamycin-induced heart failureN Iliskovic, P K Singal
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 23, 1997
Adriamycin cardiomyopathy: pathophysiology and preventionP K Singal, N Iliskovic, T Li, et al.
Molecular and Cellular Biochemistry|July 11, 2000
Adriamycin-induced heart failure: mechanism and modulationP K Singal, T Li, D Kumar, et al.
Molecular and Cellular Biochemistry|November 21, 1998
Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stressN Iliskovic, T Li, N Khaper, et al.
Molecular and Cellular Biochemistry|December 24, 1997
Adriamycin depresses in vivo and in vitro phosphatidylethanolamine N-methylation in rat heart sarcolemmaN Iliskovic, V Panagia, J Slezák, et al.
Molecular and Cellular Biochemistry|August 17, 1999
Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathyN Iliskovic, B B Hasinoff, K L Malisza, et al.
Sleep|May 22, 1998
Susceptibility of LDL to oxidative stress in obstructive sleep apneaS O Wali, A S Bahammam, H Massaeli, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|September 24, 1998
Doxorubicin-induced cardiomyopathyP K Singal, N Iliskovic
The American Journal of Pathology|February 1, 1997
Lipid lowering: an important factor in preventing adriamycin-induced heart failureN Iliskovic, P K Singal
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 23, 1997
Adriamycin cardiomyopathy: pathophysiology and preventionP K Singal, N Iliskovic, T Li, et al.
Molecular and Cellular Biochemistry|July 11, 2000
Adriamycin-induced heart failure: mechanism and modulationP K Singal, T Li, D Kumar, et al.
Molecular and Cellular Biochemistry|November 21, 1998
Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stressN Iliskovic, T Li, N Khaper, et al.
Molecular and Cellular Biochemistry|December 24, 1997
Adriamycin depresses in vivo and in vitro phosphatidylethanolamine N-methylation in rat heart sarcolemmaN Iliskovic, V Panagia, J Slezák, et al.
Molecular and Cellular Biochemistry|August 17, 1999
Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathyN Iliskovic, B B Hasinoff, K L Malisza, et al.
Sleep|May 22, 1998
Susceptibility of LDL to oxidative stress in obstructive sleep apneaS O Wali, A S Bahammam, H Massaeli, et al.
Pageof 1